| Financial Year |
March 31 2023 |
| Monetary Funds |
311,289,882.04 |
| Held-for-trading Financial Assets |
234,785,358.46 |
| Notes Receivable |
250,000.00 |
| Accounts Receivable |
176,290,974.31 |
| Advances to Suppliers |
19,847,839.29 |
| Other Receivables |
2,348,122.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
157,622,950.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,457,466.93 |
| Total Current Assets |
904,892,594.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
294,311,981.15 |
| Under-construction Projects |
158,059,938.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,600,971.24 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,425,713.00 |
| Deferred Income Tax Assets |
110,609,095.75 |
| Other Non-Current Assets |
2,580,466.87 |
| Sub-Total of Non-Current Assets |
641,790,837.11 |
| Total Assets |
1,546,683,431.22 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,567,847.20 |
| Accounts Payable |
57,712,129.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,008,162.52 |
| Taxes Payable |
8,536,931.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,051,940.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
925,112.23 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
151,585,363.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,565,743.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,691,020.05 |
| Total Liabilities |
157,276,383.48 |
| Paid-In Capital(Or Share Stock) |
177,520,000.00 |
| Capital Surplus |
579,799,276.87 |
| Surplus Reserve |
59,776,194.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
557,772,362.57 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,389,407,047.74 |
| Owner's Equity（Stockholder's Equity） |
1,389,407,047.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,546,683,431.22 |
